CDMO ten23 health launches in Switzerland with financing from 3i Group and a focus on injectablesnews2021-09-01T05:43:12+00:00September 1st, 2021|Fierce Pharma|
Novartis, NHS England move forward with ‘landmark’ access deal for cholesterol drug Leqvionews2021-08-31T18:34:58+00:00August 31st, 2021|Fierce Pharma|
Johnson & Johnson scores an FDA first with nod for twice-yearly schizophrenia drug Invega Hafyeranews2021-08-31T18:26:53+00:00August 31st, 2021|Fierce Pharma|
Merck, Amgen adopt double-digit price hikes in test to Big Pharma’s unofficial annual limits: analystnews2021-08-31T15:36:02+00:00August 31st, 2021|Fierce Pharma|
AbbVie’s Imbruvica patent win sets up solid growth path after Humira’s decline: analystnews2021-08-31T15:27:15+00:00August 31st, 2021|Fierce Pharma|
Key vaccine leaders departing FDA as COVID-19 booster questions lingernews2021-08-31T15:15:01+00:00August 31st, 2021|Fierce Pharma|
FDA approval of Pfizer’s COVID-19 vaccine spurs American confidence: Harris Pollnews2021-08-31T14:49:50+00:00August 31st, 2021|Fierce Pharma|
Servier’s beefing up in oncology through dealmaking and Tibsovo wins—and it’s not done yet, U.S. CEO saysnews2021-08-31T14:15:48+00:00August 31st, 2021|Fierce Pharma|
CDC enlists comedian to embrace the awkwardness of gynecology visits—and encourage women to gonews2021-08-31T13:15:19+00:00August 31st, 2021|Fierce Pharma|
Sanofi refiles $3.2B Translate Bio buyout with FTC to allow more time for reviewnews2021-08-31T12:47:17+00:00August 31st, 2021|Fierce Pharma|
